Cargando…

Retraction: High-Affinity Naloxone Binding to Filamin A Prevents Mu Opioid Receptor–Gs Coupling Underlying Opioid Tolerance and Dependence

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967022/ https://www.ncbi.nlm.nih.gov/pubmed/35353861 http://dx.doi.org/10.1371/journal.pone.0266627

Ejemplares similares

High-Affinity Naloxone Binding to Filamin A Prevents Mu Opioid Receptor–Gs Coupling Underlying Opioid Tolerance and Dependence
por: Wang, Hoau-Yan, et al.
Publicado: (2008)

Retraction: Naloxone’s Pentapeptide Binding Site on Filamin A Blocks Mu Opioid Receptor–Gs Coupling and CREB Activation of Acute Morphine
Publicado: (2022)

Naloxone's Pentapeptide Binding Site on Filamin A Blocks Mu Opioid Receptor–Gs Coupling and CREB Activation of Acute Morphine
por: Wang, Hoau-Yan, et al.
Publicado: (2009)

G Protein-Coupled Receptors Directly Bind Filamin A with High Affinity and Promote Filamin Phosphorylation
por: Tirupula, Kalyan C., et al.
Publicado: (2015)

Retracted: Opioid-Free Labor Analgesia: Dexmedetomidine as an Adjuvant Combined with Ropivacaine
por: Healthcare Engineering, Journal of
Publicado: (2023)

Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level
por: Moss, Ronald B., et al.
Publicado: (2020)

Naloxone for opioid toxicity and overdose in the community
por: Jauncey, Marianne, et al.
Publicado: (2021)

Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence
por: Mauger, Sofie, et al.
Publicado: (2014)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

Correction: Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level
Publicado: (2020)

Retracted: Acyclovir Combined with Naloxone in the Treatment of Viral Encephalitis: A Meta-Analysis
por: Healthcare Engineering, Journal of
Publicado: (2023)

Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in Smokers
por: Kuwabara, Hiroto, et al.
Publicado: (2014)

New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone
por: Soyka, Michael
Publicado: (2015)

Structure-Based Approach for the Prediction of Mu-opioid Binding Affinity of Unclassified Designer Fentanyl-Like Molecules
por: Floresta, Giuseppe, et al.
Publicado: (2019)

Antinociceptive effects of morphine and naloxone in mu-opioid receptor knockout mice transfected with the MORS196A gene
por: Chen, Shiou-Lan, et al.
Publicado: (2010)

Opioid Receptors and Protonation-Coupled Binding of Opioid Drugs
por: Lešnik, Samo, et al.
Publicado: (2021)

Opioids for treating refractory dyspnea in patients with heart failure: A protocol for systematic review and meta-analysis: Retraction
Publicado: (2023)

Discovery of the First Small-Molecule Opioid Pan Antagonist with Nanomolar Affinity at Mu, Delta, Kappa, and Nociceptin Opioid Receptors
por: Zaveri, Nurulain T., et al.
Publicado: (2015)

Mu-opioid receptor and receptor tyrosine kinase crosstalk: Implications in mechanisms of opioid tolerance, reduced analgesia to neuropathic pain, dependence, and reward
por: Gamble, Mackenzie C., et al.
Publicado: (2022)

Retracted: Value of CSF-Cl, CSF-GS, CSF-MALB, and CSF-ADA in Differential Diagnosis of Secondary Hydrocephalus
por: Imaging, Contrast Media & Molecular
Publicado: (2023)

Association of Take-Home Naloxone and Opioid Overdose Reversals Performed by Patients in an Opioid Treatment Program
por: Katzman, Joanna G., et al.
Publicado: (2020)

Retracted: κ-Opioid Receptor Agonist Ameliorates Postoperative Neurocognitive Disorder by Activating the Ca(2+)/CaMKII/CREB Pathway
por: Healthcare Engineering, Journal of
Publicado: (2022)

[Retracted] Inhibition of δ‑opioid receptors induces brain glioma cell apoptosis through the mitochondrial and protein kinase C pathways
por: Zhou, Lixiang, et al.
Publicado: (2023)

Naloxone precipitated withdrawal increases dopamine release in the dorsal striatum of opioid dependent men
por: Shokri-Kojori, Ehsan, et al.
Publicado: (2021)

Six-month buprenorphine-naloxone treatment is associated with neurocognitive function improvement in opioid dependence
por: Ghosh, Abhishek, et al.
Publicado: (2022)

Chronic Ethanol Consumption in Rats Produces Opioid Antinociceptive Tolerance through Inhibition of Mu Opioid Receptor Endocytosis
por: He, Li, et al.
Publicado: (2011)

[Retracted] Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen‑activated protein kinase signalling pathway
por: Chen, Quan, et al.
Publicado: (2023)

Overdose Prevention and Naloxone Prescription for Opioid Users in San Francisco
por: Enteen, Lauren, et al.
Publicado: (2010)

Opioid Education and Nasal Naloxone Rescue Kits in the Emergency Department
por: Dwyer, Kristin, et al.
Publicado: (2015)

Naloxone should remain the appropriate antidote to treat opioid overdose
por: Mégarbane, Bruno, et al.
Publicado: (2020)

Naloxone interventions in opioid overdoses: a systematic review protocol
por: Shaw, Lindsay Victoria, et al.
Publicado: (2019)

Methylnaltrexone and Naloxone for Opioid-induced Constipation in the Critical Care Setting
por: Saini, Harneel S, et al.
Publicado: (2020)

Take-home Naloxone at Opioid Treatment Programs: A Lifesaver
por: Katzman, Joanna G., et al.
Publicado: (2022)

Treatment of Opioid Withdrawal Syndrome Triggered by Oxycodone/Naloxone with Dexmedetomidine
por: Go, Se-Il, et al.
Publicado: (2023)

Impact of California Statute on Naloxone Availability and Opioid Overdose Rates
por: Gallant, Tara L., et al.
Publicado: (2023)

Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review
por: Soyka, Michael
Publicado: (2021)

Ligand-Specific Regulation of the Endogenous Mu-Opioid Receptor by Chronic Treatment with Mu-Opioid Peptide Agonists
por: Murányi, Marianna, et al.
Publicado: (2013)

Activity of opioid ligands in cells expressing cloned mu opioid receptors
por: Gharagozlou, Parham, et al.
Publicado: (2003)

Mu Opioid Receptor Gene: New Point Mutations in Opioid Addicts
por: Dinarvand, Amin, et al.
Publicado: (2014)

[Retracted] Downregulation of δ opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug‑resistant human hepatocellular carcinoma cells to 5‑FU
por: Tang, Bo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h35ll09lu437enpf9cdciljmgp